a.k.a. Brands Holding Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $122.6M
- Price
- $11.15
- % Change (Daily % change from the live per-ticker quote feed.)
- +2.70%
- Volume
- 337
About
a.k.a. Brands Holding Corp. operates a portfolio of online fashion brands in the United States, Australia, New Zealand, and internationally. The company offers dresses, tops, shoes, and accessories for customers between the ages of 15 and 25; dresses for special occasions for customers between 25 and 34; streetwear apparel, footwear, headwear, and accessories for male consumers between the ages of 18 and 35; and streetwear wardrobe staples through its online stores under the Princess Polly, Petal & Pup, Culture Kings, and mnml brands. It also operates physical retail stores. The company was founded in 2018 and is headquartered in San Francisco, California. a.k.a. Brands Holding Corp. is a subsidiary of New Excelerate, L.P.
Quick stats
Shares outstanding11.0M
Computed float792.5K
Float / shares7.2%
Key info
SectorConsumer Cyclical
IndustryApparel - Retail
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001865107
Websitehttp://www.aka-brands.com
AI Summary
AI-generated1/14
majorbullishoperations update
Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
Aureka Biotechnologies announced its AuraIDE foundation model won first place in the AIntibody global AI antibody design competition, with results published in Nature Biotechnology.
The winning AI-designed antibody achieved an affinity of 94.7pM, surpassing the best experimental result of 113 pM and representing a 2,000-fold improvement over the parental antibody.
Aureka secured three of the top five spots in the primary challenge, validating the model's ability to replace iterative wet-lab cycles with computation.